Crossmark

Chitosan-modified manganese oxide-conjugated methotrexate nanoparticles delivering 5-aminolevulinic acid as a dual-modal T1–T2* MRI contrast agent in U87MG cell detection

Crossref DOI link: https://doi.org/10.1007/s10334-024-01169-4

Published Online: 2024-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ayyami, Yasin

Ghorbani, Marjan

Dastgir, Masoumeh

Malekzadeh, Reza

Mortezazadeh, Tohid
License Information

Text and Data Mining valid from 2024-05-25

Version of Record valid from 2024-05-25
More Information

Article History

Received: 23 January 2024

Revised: 8 May 2024

Accepted: 16 May 2024

First Online: 25 May 2024

Declarations

:

: The author declares that there are no conflicts of interest, financial or other.

: All of this project was approved by the Tabriz University of Medical Sciences under the research ethics certificate ID: IR.TBZMED.VCR.REC.1401.103.

Document is current

Any future updates will be listed below